In a potential game changing move for therapeutic pet diets – Royal Canin heralds its unique, Direct Digital Access to Clinical Pet Nutrition by partnering with Amazon for supplies.
ROYAL CANIN U.S., a global leader in health nutrition and a subsidiary of Mars, Incorporated, announced the official availability of its veterinary therapeutic product line within Amazon’s stores.
The expansion allows pet owners to purchase veterinarian-recommended therapeutic diets online while benefiting from Amazon Prime fast delivery, automated recurring subscription options, and an integrated veterinary prescription verification process.
This initiative bridges the gap between clinical veterinary care and modern e-commerce convenience, helping ensure pet owners maintain uninterrupted long-term compliance with therapeutic nutritional plans.
Integrated Veterinary Authorization and Compliance
Therapeutic diets are formulated to manage specific, diagnosed feline and canine medical conditions and require clinical veterinary oversight. To maintain regulatory compliance and medical safety, Amazon’s fulfillment portal incorporates a digital prescription verification engine:
-
Order Initiation: The pet owner selects the specific Royal Canin therapeutic formula prescribed by their veterinarian.
-
Clinic Verification: During checkout, the customer provides their veterinary clinic’s information.
-
Veterinary Approval: Amazon’s healthcare verification system contacts the treating clinic to confirm a valid prescription on file before the order is dispatched.
-
Subscription Automation: Once verified, pet owners can schedule recurring deliveries through Amazon’s Subscribe & Save service to prevent gaps in therapeutic treatment.
Therapeutic Categories Included in the Amazon Rollout
The Amazon distribution expansion encompasses Royal Canin’s core veterinary therapeutic portfolio, designed for life-stage and disease-specific management:
Clinical Category |
Target Pathology / Health Need |
Formula Characteristics |
Dermatology |
Environmental allergies, adverse food reactions, and cutaneous barrier support. |
Hydrolyzed proteins and targeted omega-3/6 fatty acids. |
Gastrointestinal |
Acute/chronic enteropathies, microbiome imbalance, and malabsorption. |
Highly digestible proteins, prebiotics, and adjusted fat levels. |
Urinary (S/O) |
Feline lower urinary tract disease (FLUTD), struvite, and calcium oxalate urolithiasis. |
Relative Supersaturation (RSS) methodology to reduce crystal formation. |
Renal & Cardiac |
Chronic kidney disease (CKD) and cardiovascular management. |
Low phosphorus, restricted sodium, and EPA/DHA fortification. |
Weight Management |
Canine/feline obesity and metabolic disease. |
High fiber and protein ratios designed for safe satiety. |
Executive Commentary & Clinical Rationale
Highlighting the strategy behind expanding into digital marketplace platforms, Dr. Todd East, Director of Veterinary Affairs at Royal Canin North America, stated:
“Royal Canin is committed to partnering with veterinarians to support pets throughout all stages of their lives. By expanding Royal Canin therapeutic products in Amazon’s stores, we’re making it easier for pet owners to learn about the diets their veterinarian recommended and maintain continuity of care by accessing those nutritional solutions with the convenience they expect from modern shopping.”
Industry Impact: Omnichannel Fulfillment in Veterinary Practice
